Functional Gastrointestinal Disorders Clinical Trial
Official title:
The Effects of Imagery Treatments vs Progressive Muscle Relaxation Therapy in Terms of Clinical, Psychological and Physiological Aspects Among Patients With Functional Abdominal Bloating
Verified date | November 2022 |
Source | Universiti Sains Malaysia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
65% of the general population reported experiencing moderate to severe bloating symptoms. Bloating could be disturbing to patients and frustrating to the physicians as an effective treatment is still lacking. Guided Imagery (GI) involves the structured visualisation of mental images with somatic sensory; whereas Progressive Muscle Relaxation (PMR) focuses on tightening and relaxing the body's specific muscle groups. The development and validation of GI or PMR interventions to treat patients with functional abdominal bloating are relatively novel.
Status | Completed |
Enrollment | 96 |
Est. completion date | August 30, 2022 |
Est. primary completion date | June 28, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Participants with abdominal bloating as determined using the Malay version Rome III criteria which was validated and translated by past researchers (Lee et al, 2012) and/or patients who were suggested by clinicians. - Participants must be 18 years and above, and of either gender. - Participants are able to read, write, or understand the Malay language. Exclusion Criteria: - Patients with abdominal bloating due to organic disorder - Patients with recent abdominal surgeries (within 3 months) or previous major abdominal surgeries - Patients with major neurological and psychological disorders including stroke, schizophrenia, major depression. - Patients with medical history which may be the red flag for other FGIDs and organic disorders . - Patients who are on psychotropic medications or psychotherapy which may confound outcome of imagery of sham intervention. |
Country | Name | City | State |
---|---|---|---|
Malaysia | Universiti Sains Malaysia | Kubang Kerian | Kelantan |
Lead Sponsor | Collaborator |
---|---|
Universiti Sains Malaysia |
Malaysia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Symptoms severity | Measured using the Malay version of Bloating Severity Questionnaire (BSQ-M). It consists of two components: five-item Sev24 and seven-item SevGen. The responses were in a multiple-choice answer format on different degrees of effect towards individuals on the basis of intensity, frequency and severity (less severe to more severe; range 1 to 4,5,6,7 or 8 varied by items). Higher scores in BSQ indicate worse severity. | 1 month | |
Secondary | Health belief | Measured using the Malay-Language Health of Bloating (HB-Bloat) Scale. The questionnaire consists of 12 items and 3 domains: attitude (3 items), subjective norm (5 items), perceived control towards self-management (4 items). All responses were measured on a five-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). | 1 month | |
Secondary | Health seeking Intention | Measured using Health Seeking Intention for Abdominal Bloating Scale. It is a 5 point Likert scale that consists of 1 domain and 1 item. 1 indicates "strongly diagree" while 5 indicates "strongly agree" | 1 month | |
Secondary | Health promoting behavior | Measured using Health Promoting Behavior Scale of Abdominal Bloating. The questionnaire consists of 4 domains and 15 items. The questionnaire is a 5 point Likert scales, whereby 1 is considered strongly disagree and 5 is considered strongly agree. | 1 month | |
Secondary | Anxiety | Measured using the Malay version of Hospital Anxiety and Depression Scale (HADS). It comprises of 14 items, seven of which is related to anxiety symptoms. Each item is coded from 0 to 3. The scores for anxiety and depression can therefore vary from 0 to 21, depending on the presence and severity of the symptoms. A score between 0 and 7 does not indicate the presence of the symptoms of anxiety; a score between 8 and 10 indicates the presence of a moderate symptom; a score of 11 and above indicates a significant number of symptoms of anxiety corresponding to confirmed cases. | 1 month | |
Secondary | Depression | Measured using the Malay version of Hospital Anxiety and Depression Scale (HADS). It comprises of 14 items, seven of which is related to anxiety symptoms. Each item is coded from 0 to 3. The scores for anxiety and depression can therefore vary from 0 to 21, depending on the presence and severity of the symptoms. A score between 0 and 7 does not indicate the presence of the symptoms of anxiety; a score between 8 and 10 indicates the presence of a moderate symptom; a score of 11 and above indicates a significant number of symptoms of anxiety corresponding to confirmed cases. | 1 month | |
Secondary | Abdominal circumference | Using a non-stretch metric tape | 1 month | |
Secondary | Electrical activity | Measured using the Megawin ME6000 Electromyograph | 1 month | |
Secondary | Quality of life for patients with abdominal bloating | Measured using the Malay version of Bloating Quality of Life (BLQoL-M) Questionnaires. The responses for BLQoL were in a 7-point Likert scale on different degrees of impact towards individual ranging from 1 = "never/not related to me" to 7 = "always". Higher scores in BLQoL indicate higher impact towards QoL. | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05936112 -
Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study
|
N/A | |
Completed |
NCT02565355 -
Targeted Food Elimination for Treatment of Functional Gastrointestinal Diseases in Children
|
N/A | |
Completed |
NCT02657668 -
Emotion Focused Therapy in Irritable Bowel Syndrome Patients
|
N/A | |
Completed |
NCT02731664 -
GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans
|
Phase 1 | |
Recruiting |
NCT06205446 -
Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction
|
N/A | |
Recruiting |
NCT05718960 -
Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia
|
N/A | |
Terminated |
NCT04247100 -
A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders
|
N/A | |
Recruiting |
NCT03625674 -
Impact of Stigma on Compliance to Medication in Functional Dyspepsia
|
N/A | |
Completed |
NCT03252743 -
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.
|
N/A | |
Recruiting |
NCT05832528 -
Low FODMAP Diet in FD (PDS)
|
N/A | |
Completed |
NCT02936713 -
Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms
|
N/A | |
Terminated |
NCT01712412 -
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
|
Phase 2 | |
Completed |
NCT00564525 -
Study of Medication for Functional Abdominal Pain in Children
|
Phase 4 | |
Recruiting |
NCT05987813 -
Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation
|
N/A | |
Completed |
NCT04155801 -
A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances
|
N/A | |
Recruiting |
NCT05880199 -
BSGM to Evaluate Patients With GI Symptoms
|
||
Recruiting |
NCT04625881 -
Effects of an Apple Derived Fibre Supplement on Constipation
|
Phase 3 | |
Completed |
NCT03608735 -
Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
|
||
Recruiting |
NCT04773158 -
Systematic Pediatric Assessment of Rome Criteria
|
N/A | |
Completed |
NCT02306369 -
Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents
|
N/A |